| Q39127729 | Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction. |
| Q38626779 | Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure |
| Q36313675 | Cardiorenal biomarkers in acute heart failure |
| Q38125509 | Clinical utility of biomarkers in chronic kidney disease and chronic heart failure |
| Q89692604 | Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure |
| Q61799192 | Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis |
| Q36345739 | Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events |
| Q87353510 | Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study |
| Q37184401 | Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF |
| Q38055505 | Experimental biomarkers in heart failure: an update |
| Q36756211 | Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C |
| Q34512274 | Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. |
| Q84242255 | Management of the cardiorenal syndrome in acute heart failure |
| Q47557980 | Methods of Estimating Kidney Function for Drug Dosing in Special Populations |
| Q38252731 | Novel renal biomarkers to assess cardiorenal syndrome |
| Q35846796 | Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels |
| Q41166002 | Prognostic Significance of Interleukin-34 (IL-34) in Patients With Chronic Heart Failure With or Without Renal Insufficiency |
| Q41471283 | Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. |
| Q90281720 | Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina Pectoris |
| Q50856043 | Serum biomarkers and the prognosis of AMI patients. |
| Q45768858 | The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure |
| Q87248883 | The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT |
| Q48586571 | The potential of cystatin-C to evaluate the prognosis of acute heart failure: A comparative study |